What Is Chromoendoscopy and Why Is It Performed?

Chromoendoscopy is a technique in which dyes or digital filters are applied during an endoscopy to make subtle changes in the lining of the digestive tract easier to see. Standard endoscopy uses white light alone, which can miss flat or early-stage abnormalities that blend into surrounding tissue. By adding color contrast, chromoendoscopy helps gastroenterologists spot precancerous patches, early cancers, and inflammatory changes that would otherwise go undetected. The technique has become especially valuable in screening patients who face elevated cancer risk, and understanding when and why it is used can help you make sense of a procedure your doctor may recommend.

How It Works in Practice

During a conventional endoscopy, a thin flexible tube with a camera is passed through the mouth or rectum to examine the digestive tract under white light. In dye-based chromoendoscopy, the endoscopist sprays a liquid stain directly onto the mucosal surface through a catheter threaded through the scope’s working channel. The dye pools in crevices, highlights surface patterns, and can be absorbed differently by normal versus abnormal tissue. This transforms a relatively uniform-looking pink surface into a detailed map of ridges, pits, and color variations that reveal what is happening at a cellular level.

The entire process adds time to a standard endoscopy. One controlled trial found that adding chromoendoscopy extended the median examination time from about 19 minutes to roughly 27 minutes, a meaningful but not dramatic increase. The dye itself is inexpensive, and no special equipment beyond a spray catheter is needed for the traditional dye-spraying approach, which is one reason the technique has been widely adopted even in resource-limited settings.

The Three Categories of Stains

Not all chromoendoscopy dyes work the same way. They fall into three broad families, each suited to different clinical questions.

Absorptive stains: These are taken up by specific cell types. Methylene blue, for example, is absorbed by cells in the small intestine and colon but not by the normal lining of the esophagus or stomach. Lugol’s iodine solution reacts with glycogen in healthy squamous cells of the esophagus, staining them dark brown and leaving abnormal or cancerous patches unstained. Both stains help identify tissue that has changed its character.
Contrast stains: Indigo carmine is the most common. It is not absorbed by cells at all. Instead, it settles into grooves and depressions on the mucosal surface, outlining surface architecture the way ink fills the lines of a fingerprint. This makes it ideal for revealing the pit patterns that distinguish benign from potentially dangerous polyps.
Reactive stains: Congo red changes color in response to acid secretion, helping identify areas of the stomach that produce acid versus those that do not. It is used less frequently than absorptive and contrast stains but has a niche role in evaluating gastric conditions.

These categories matter because the choice of stain depends entirely on what the endoscopist is looking for and where in the digestive tract they are looking.

Surveillance in Inflammatory Bowel Disease

One of the strongest reasons chromoendoscopy exists is to watch for cancer in people with longstanding inflammatory bowel disease. Patients with ulcerative colitis or Crohn’s disease affecting the colon face a higher lifetime risk of colorectal cancer, and dysplasia in these patients tends to appear as flat, subtle lesions rather than the obvious raised polyps found in the general population. Standard white-light endoscopy can easily miss them.

A systematic review of randomized trials found that chromoendoscopy roughly doubled the likelihood of detecting patients with dysplasia compared with standard-definition white-light endoscopy.² A separate meta-analysis confirmed that chromoendoscopy outperformed both white-light endoscopy and narrow-band imaging for dysplasia detection in this population.³ That advantage is not trivial. Finding dysplasia early in IBD patients can mean the difference between targeted removal of a small lesion and a major surgery down the road.

A randomized trial comparing chromoendoscopy with autofluorescence imaging, another advanced technique, found dysplasia in about 19% of patients examined with chromoendoscopy versus 12% with autofluorescence, with nearly three times as many dysplastic lesions detected per patient in the chromoendoscopy group.⁴ Findings like these are why major gastroenterology societies now recommend chromoendoscopy as part of surveillance protocols for IBD patients.

Evaluating Barrett’s Esophagus

Barrett’s esophagus is a condition where the normal lining of the lower esophagus is replaced by tissue that resembles the intestinal lining, usually as a consequence of chronic acid reflux. The concern with Barrett’s is that it can progress through stages of dysplasia toward esophageal cancer. Surveillance endoscopies aim to catch dysplasia early, but the standard approach involves taking random biopsies at set intervals along the Barrett’s segment, which amounts to sampling only a fraction of the tissue at risk.

Chromoendoscopy, particularly when combined with magnification, improves the odds of spotting abnormal areas and targeting biopsies more precisely. Acetic acid chromoendoscopy has shown especially strong results. When sprayed on Barrett’s mucosa, acetic acid causes a temporary whitening reaction. Dysplastic tissue loses this whitening faster than normal Barrett’s tissue, creating a visible contrast that highlights suspicious zones.⁵ One large cohort study found a roughly sixfold increase in neoplasia detection per patient with acetic acid chromoendoscopy compared with the standard random biopsy protocol, and the number of biopsies needed to find one case of neoplasia dropped from over 600 to about 40.⁶

A meta-analysis pooling nine studies found that acetic acid chromoendoscopy had a pooled sensitivity above 90% and specificity above 95% for diagnosing high-grade dysplasia or early cancer in Barrett’s esophagus.⁷ Acetic acid is cheap, widely available, and simple to apply, which makes it one of the more practical enhancements to Barrett’s surveillance. It is worth noting, though, that the acetowhitening reaction fades within a few minutes, so the endoscopist needs to work systematically and efficiently during the window of enhanced visibility.⁸

Methylene blue has also been studied for Barrett’s surveillance, but a meta-analysis found no significant improvement over random biopsy for detecting specialized intestinal metaplasia, dysplasia, or early cancer.⁹ Combined with safety concerns discussed below, methylene blue has largely fallen out of favor for this particular application.

Colorectal Polyp Characterization

Beyond just finding lesions, chromoendoscopy helps endoscopists decide what a lesion actually is. In the colon, this is done primarily through pit pattern analysis. When indigo carmine is sprayed over a polyp and viewed under magnification, the surface reveals intricate patterns of tiny pits and grooves. These patterns have been classified into categories that correlate strongly with what a pathologist would see under a microscope.

A meta-analysis covering over 5,000 colorectal lesions found that pit pattern classification using magnifying chromoendoscopy had a pooled sensitivity of about 93% and specificity of about 87% for distinguishing neoplastic from non-neoplastic polyps.¹⁰ In practical terms, this means an experienced endoscopist using chromoendoscopy can often make a real-time judgment about whether a polyp needs to be removed or can be left alone, reducing unnecessary biopsies and improving efficiency.

This “optical diagnosis” concept is gaining traction. If you can accurately characterize a small polyp during the procedure itself, you can make decisions on the spot about removal, follow-up intervals, and even whether the tissue needs to be sent to the lab at all. That has real implications for healthcare costs and patient convenience.

Detecting Early Gastric Cancer

Chromoendoscopy has also proven useful in the stomach, particularly for detecting early gastric cancer and premalignant changes like intestinal metaplasia and atrophic gastritis. A meta-analysis found that chromoendoscopy had a pooled sensitivity of 90% and specificity of 82% for these conditions, and it performed significantly better than standard white-light endoscopy.¹¹ This is particularly relevant in parts of the world where gastric cancer is common and screening programs exist, such as East Asia. In Western countries, where gastric cancer is less prevalent, the technique is used selectively in patients known to have risk factors or suspected premalignant changes.

Virtual Chromoendoscopy and How It Differs

The term “chromoendoscopy” now covers two distinct approaches. Traditional dye-spraying chromoendoscopy uses physical stains as described above. Virtual chromoendoscopy, also called electronic chromoendoscopy, achieves enhanced contrast digitally. Technologies like narrow-band imaging (NBI), flexible spectral imaging chromoendoscopy (FICE), and blue laser imaging use optical filters or software algorithms built into the endoscope to highlight surface vessels and mucosal patterns without any dye at all.

Virtual techniques are faster and more convenient. There is no spray catheter to set up, no dye to prepare, and no waiting for the stain to settle. But faster does not always mean better. A randomized trial comparing NBI and FICE with standard white-light endoscopy at screening colonoscopy found that neither virtual technique increased the number of adenomas detected per patient or reduced the miss rate compared with white light alone.¹² That finding, which surprised many in the field, suggests that virtual chromoendoscopy’s strength lies more in characterizing lesions already found than in finding new ones.

In IBD surveillance specifically, one study found that dye-spraying and virtual chromoendoscopy had similar sensitivity and specificity for detecting dysplasia, though the agreement between observers was somewhat lower with the dye-spraying approach.¹³ The evidence is still evolving on whether virtual techniques can fully replace dye-based methods, and current guidelines generally treat them as complementary rather than interchangeable.

Safety Concerns Around Methylene Blue

One issue that has generated real debate is the safety of methylene blue as a chromoendoscopy agent. Methylene blue is a photosensitizer, meaning it can generate reactive oxygen species when exposed to light. Since endoscopy involves intense white light shining directly on dye-coated tissue, the concern is that methylene blue could damage the DNA of the very cells being examined.

A study in the journal Gut demonstrated that methylene blue caused significant DNA damage in colonocyte cell lines and in biopsies from patients undergoing chromoendoscopy, especially when light was present. Indigo carmine, by contrast, showed no such effect under the same conditions.¹⁴ A separate study published in The Lancet confirmed that DNA damage was increased in Barrett’s mucosa after chromoendoscopy with methylene blue, an effect that appeared dependent on the combination of the dye and endoscopic white light.¹⁵

The picture is not entirely one-sided, however. A later study evaluating an oral modified-release formulation of methylene blue found no evidence of DNA damage in colonic biopsies taken before and after exposure, with no serious adverse events reported.¹⁶ The differences may relate to the formulation, concentration, or duration of light exposure. In practice, the genotoxicity concern has nudged many endoscopists toward indigo carmine and acetic acid, which do not carry the same risk profile. If your doctor does recommend methylene blue chromoendoscopy, it is reasonable to ask about the rationale and whether an alternative stain would serve the same purpose.

Cost-Effectiveness in Surveillance Programs

Adding any step to a medical procedure raises the question of whether the benefit justifies the cost. A cost-effectiveness analysis focused on colorectal cancer surveillance in ulcerative colitis found that chromoendoscopy was actually both more effective and less costly than standard white-light endoscopy at every surveillance interval studied. Compared with no surveillance at all, chromoendoscopy became cost-effective at surveillance intervals of seven years or longer.¹⁷ The reason is straightforward: better detection means catching problems earlier, which avoids the much higher costs of treating advanced cancer. The dye itself costs very little, and the added procedure time, while real, is modest relative to the potential savings from prevented cancers and avoided surgeries.

The Role of Chromoendoscopy in Lynch Syndrome

Lynch syndrome is a hereditary condition that significantly increases the risk of several cancers, particularly colorectal cancer. People with Lynch syndrome typically begin colonoscopy screening at a younger age and undergo it more frequently than the general population. The European Society of Gastrointestinal Endoscopy has suggested that chromoendoscopy may benefit individuals with Lynch syndrome undergoing colonoscopy, though routine use needs to be weighed against costs, training requirements, and practical considerations.¹⁸ The evidence here is less robust than in IBD surveillance, and practice varies between centers. Some high-risk clinics use chromoendoscopy routinely for Lynch patients; others reserve it for cases where standard colonoscopy raises suspicion.

Artificial Intelligence and Optical Diagnosis

One of the more interesting developments is the pairing of chromoendoscopy with artificial intelligence. Computer-aided diagnosis systems can analyze the enhanced images produced by electronic chromoendoscopy in real time and offer predictions about whether a polyp is likely to be neoplastic. A study found that AI-assisted endoscopists using electronic chromoendoscopy achieved a negative predictive value above 97% for small polyps in the rectum and sigmoid colon, with AI agreeing with the endoscopist’s diagnosis in over 97% of cases.¹⁹

The practical implication is a “diagnose-and-leave” strategy: if both the AI system and the endoscopist agree that a tiny polyp is benign, it could be left in place rather than removed and sent for pathology. This would spare patients unnecessary polypectomies, reduce pathology costs, and shorten procedures. The approach is still being validated and is not yet standard care everywhere, but it represents a natural evolution of the optical diagnosis capabilities that chromoendoscopy first made possible. The dye or digital filter provides the enhanced image; the AI provides a second opinion on what that image shows.

Who Actually Gets Chromoendoscopy

Despite its advantages, chromoendoscopy is not used in every endoscopy. The technique is most commonly employed in specific clinical scenarios where the stakes of missing a lesion are high and where standard white-light endoscopy has known limitations. You are most likely to encounter it if you have longstanding ulcerative colitis or Crohn’s colitis and are undergoing a surveillance colonoscopy, if you are being monitored for Barrett’s esophagus, if a polyp was spotted and the endoscopist wants a closer look at its surface architecture before deciding on management, or if you are at elevated risk for gastric cancer.

For routine screening colonoscopies in average-risk individuals, chromoendoscopy is not typically standard practice. The added time and training requirements outweigh the incremental benefit in a population where the detection rate with standard techniques is already reasonable. That said, individual endoscopists with chromoendoscopy expertise may use it selectively even in average-risk patients if they encounter suspicious-looking areas during the procedure. The trend is toward making these enhanced imaging tools more accessible, and as virtual chromoendoscopy becomes standard on newer endoscope platforms, the line between “standard” and “enhanced” endoscopy continues to blur.